🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/09/2022 | 0,6900 USD |
| 14/06/2022 | 0,6900 USD |
| 14/03/2022 | 0,6900 USD |
| 14/12/2021 | 0,6900 USD |
| 14/09/2021 | 0,6500 USD |
| 14/06/2021 | 0,6500 USD |
| 12/03/2021 | 0,6202 USD |
| 14/12/2020 | 0,6202 USD |
| 14/09/2020 | 0,5821 USD |
| 12/06/2020 | 0,5821 USD |
| 13/03/2020 | 0,5821 USD |
| 13/12/2019 | 0,5821 USD |
| 13/09/2019 | 0,5248 USD |
| 14/06/2019 | 0,5248 USD |
| 14/03/2019 | 0,5248 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/05/2001 | 73,09 | 73,10 | 71,57 | 71,66 | -2,97% | 2,09% | 6.538.682 |
| 21/05/2001 | 74,09 | 74,48 | 72,93 | 73,86 | +0,00% | 2,09% | 5.217.573 |
| 18/05/2001 | 75,37 | 75,53 | 72,87 | 73,86 | -1,53% | 3,53% | 4.496.234 |
| 17/05/2001 | 74,05 | 75,50 | 74,00 | 75,00 | +0,64% | 2,02% | 5.541.195 |
| 16/05/2001 | 72,85 | 75,28 | 72,82 | 74,52 | +2,90% | 3,37% | 6.466.370 |
| 15/05/2001 | 72,47 | 72,66 | 71,12 | 72,42 | -1,03% | 2,13% | 4.025.578 |
| 14/05/2001 | 72,46 | 73,18 | 71,61 | 73,18 | +0,99% | 2,16% | 3.053.767 |
| 11/05/2001 | 71,76 | 72,52 | 71,61 | 72,46 | -0,76% | 1,26% | 5.220.822 |
| 10/05/2001 | 73,78 | 74,19 | 72,62 | 73,02 | -1,03% | 2,12% | 3.021.070 |
| 09/05/2001 | 73,38 | 73,97 | 73,28 | 73,78 | +1,15% | 0,94% | 4.193.258 |
| 08/05/2001 | 72,61 | 73,03 | 71,93 | 72,94 | -0,60% | 1,52% | 3.219.561 |
| 07/05/2001 | 72,80 | 73,47 | 71,90 | 73,38 | +0,69% | 2,16% | 2.964.897 |
| 04/05/2001 | 71,61 | 73,35 | 71,39 | 72,87 | +1,46% | 2,73% | 3.341.443 |
| 03/05/2001 | 71,61 | 72,37 | 71,04 | 71,82 | +0,48% | 1,85% | 3.935.659 |
| 02/05/2001 | 72,09 | 72,14 | 70,85 | 71,48 | -0,91% | 1,79% | 4.566.136 |
| 01/05/2001 | 71,71 | 72,46 | 71,61 | 72,14 | -0,49% | 1,18% | 4.869.218 |
| 30/04/2001 | 72,94 | 73,14 | 72,28 | 72,49 | +0,42% | 1,18% | 4.660.246 |
| 27/04/2001 | 71,56 | 72,47 | 71,09 | 72,19 | +1,07% | 1,93% | 4.171.983 |
| 26/04/2001 | 71,19 | 72,09 | 70,73 | 71,42 | -0,01% | 1,92% | 4.794.600 |
| 25/04/2001 | 70,10 | 71,55 | 69,95 | 71,43 | +1,91% | 2,27% | 4.680.158 |
| 24/04/2001 | 70,85 | 71,56 | 69,70 | 70,10 | -1,06% | 2,63% | 5.098.939 |
| 23/04/2001 | 71,04 | 71,47 | 70,60 | 70,85 | +0,87% | 1,22% | 6.132.896 |
| 20/04/2001 | 72,04 | 72,42 | 68,70 | 70,24 | -5,95% | 5,17% | 16.874.162 |
| 19/04/2001 | 75,12 | 75,35 | 73,86 | 74,69 | -1,30% | 1,99% | 5.655.008 |
| 18/04/2001 | 76,23 | 76,74 | 74,62 | 75,67 | -1,92% | 2,78% | 8.203.115 |
| 17/04/2001 | 74,90 | 77,15 | 74,90 | 77,15 | +2,21% | 3,01% | 4.985.441 |
| 16/04/2001 | 75,86 | 76,74 | 74,90 | 75,48 | -0,50% | 2,42% | 4.578.502 |
| 12/04/2001 | 72,90 | 76,05 | 72,90 | 75,86 | +3,05% | 4,32% | 5.039.622 |
| 11/04/2001 | 73,85 | 73,98 | 73,12 | 73,62 | -1,58% | 1,16% | 5.062.154 |
| 10/04/2001 | 74,90 | 75,09 | 73,95 | 74,80 | +0,50% | 1,52% | 6.191.584 |